Trademark: 90883652
Status Date
Saturday, February 10, 2024
Filing Date
Sunday, August 15, 2021
Published for Opposition
Tuesday, June 13, 2023
44 Providing medical information in the nature of clinical patient-level information to life science companies and other medical professionals on a scheduled basis in the form of a cancer-type specific dataset containing clinical patient-level information that has been extracted from an Electronic Medical Records System and enriched with data from other sources that contain reimbursement claims or drug products dispensed associated with those same patients
Feb 16, 2024
On Hold - Electronic Record Review Required
Feb 13, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 10, 2024
Allowed Principal Register - Sou Accepted
Feb 10, 2024
Statement Of Use Processing Complete
Jan 19, 2024
Use Amendment Filed
Feb 8, 2024
Case Assigned To Intent To Use Paralegal
Jan 19, 2024
Teas Statement Of Use Received
Aug 8, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 13, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 13, 2023
Published For Opposition
May 24, 2023
Notification Of Notice Of Publication E-Mailed
May 5, 2023
Approved For Pub - Principal Register
May 2, 2023
Teas/Email Correspondence Entered
May 1, 2023
Correspondence Received In Law Office
May 1, 2023
Teas Response To Office Action Received
Nov 1, 2022
Notification Of Non-Final Action E-Mailed
Nov 1, 2022
Non-Final Action E-Mailed
Nov 1, 2022
Non-Final Action Written
Oct 3, 2022
Teas/Email Correspondence Entered
Oct 3, 2022
Correspondence Received In Law Office
Oct 3, 2022
Teas Response To Office Action Received
Apr 9, 2022
Notification Of Non-Final Action E-Mailed
Apr 9, 2022
Non-Final Action E-Mailed
Apr 9, 2022
Non-Final Action Written
Mar 29, 2022
Assigned To Examiner
Oct 5, 2021
New Application Office Supplied Data Entered
Aug 18, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
